Literature DB >> 12655789

Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.

Mariana S de Lorenzo1, Giselle V Ripoll, Hitoshi Yoshiji, Masaharu Yamazaki, Unnur P Thorgeirsson, Daniel F Alonso, Daniel E Gomez.   

Abstract

Tissue inhibitor of metalloproteinases-1 (TIMP-1) has emerged as a multifunctional protein that plays contrasting roles during angiogenesis and cancer spread. We have investigated the growth, vascularization and metastasis of B16 melanoma cells in a transgenic mouse model with elevated TIMP-1 levels in the systemic circulation. Transgenic C57BL/6j-CBA mice overexpressing human TIMP-1 in the liver under the control of the mouse albumin promoter/enhancer were employed. An early subcutaneous growth advantage and an increased tumor angiogenic response were observed in transgenic animals with respect to wild-type hybrid mice. On the contrary, there was a dramatic decrease in the lung colonizing ability of B16 melanoma cells in TIMP-1 transgenic mice. No significant effect on metastasis formation was observed in another transgenic mouse model with increased TIMP-1 expression in lungs but low plasma levels, where the transgene was placed under the control of the murine mammary tumor virus promoter. These results support the notion that TIMP-1 displays paradoxical effects on tumor progression and suggest that circulating TIMP-1 is efficient in suppressing lung colonization of melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655789

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  8 in total

1.  Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.

Authors:  H Cui; B Seubert; E Stahl; H Dietz; U Reuning; L Moreno-Leon; M Ilie; P Hofman; H Nagase; B Mari; A Krüger
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

2.  Caloric restriction reduces growth of mammary tumors and metastases.

Authors:  Mariana S De Lorenzo; Erdene Baljinnyam; Dorothy E Vatner; Patricio Abarzúa; Stephen F Vatner; Arnold B Rabson
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

3.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Rian Disci; Sidika Kurul; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

5.  Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis.

Authors:  Qing-He Nie; Guo-Rong Duan; Xin-Dong Luo; Yu-Mei Xie; Hong Luo; Yong-Xing Zhou; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

6.  'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.

Authors:  Mariana S De Lorenzo; Wen Chen; Erdene Baljinnyam; María J Carlini; Krista La Perle; Sanford P Bishop; Thomas E Wagner; Arnold B Rabson; Dorothy E Vatner; Lydia I Puricelli; Stephen F Vatner
Journal:  Aging Cell       Date:  2013-10-13       Impact factor: 9.304

Review 7.  Rho GTPases as therapeutic targets in cancer (Review).

Authors:  G A Cardama; N Gonzalez; J Maggio; P Lorenzano Menna; D E Gomez
Journal:  Int J Oncol       Date:  2017-08-09       Impact factor: 5.650

8.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.